FDA's move to ban fluoride prescriptions for children sparks backlash from ADA and health experts
MARYLAND: In a move sparking intense debate across the dental and public health sectors, the U.S. Food and Drug Administration (FDA) has announced it will remove all concentrated, ingestible fluoride prescription products for children from the U.S. market — a decision that has drawn immediate opposition from the American Dental Association (ADA) and other medical voices.
According to the FDA’s official statement, these products — typically prescribed to children aged 6 months to 16 years — have never received formal approval. The agency has set an October 31 deadline to conclude a safety review and public comment period, after which it will begin removing these products from circulation.
“The best way to prevent cavities in children is by avoiding excessive sugar intake and promoting good dental hygiene — not by altering a child’s microbiome,”
— Dr. Marty Makary, FDA Commissioner
The FDA cited concerns about the systemic effects of fluoride ingestion, particularly in children. Officials warned that the gut microbiome, thyroid function, cognitive development, and weight gain could be adversely impacted — risks that warrant precautionary regulation.
ADA pushes back
The American Dental Association swiftly responded, arguing that fluoride prescription supplements have long been essential for children in areas without fluoridated water. ADA President Dr. Brett Kessler expressed concern that banning these products could harm underserved communities, particularly rural and low-income families.
“Proposals like this stand to hurt rural America, not make them healthier,”
— Dr. Brett Kessler, ADA President
The ADA also emphasized that existing research does not conclusively prove harm from low-dose fluoride use. In fact, the organization’s own 2010 guidelines continue to recommend fluoride supplements for cavity-prone children — especially those without access to other sources of fluoride.
A divided landscape on fluoride policy
The FDA’s decision comes amid growing national skepticism toward fluoride use:
- Utah recently became the first U.S. state to ban fluoride in public water systems, with Florida potentially following.
- Texas Attorney General Ken Paxton has launched an investigation into fluoride toothpaste marketing by major corporations like Colgate-Palmolive and Procter & Gamble, calling their messaging “misleading and dangerous.”
- Florida is reportedly considering a similar measure.
Kennedy praises fluoride ban as path to "Make America Healthy Again"
The U.S. Department of Health and Human Services (HHS) has announced it will actively promote safe and effective dental hygiene practices for children — approaches that are both practical and free from adverse effects on gut health. The agency’s stance aligns with a growing movement to reduce reliance on chemical-based interventions in child health programs.
Health Secretary Robert F. Kennedy Jr. hailed the FDA’s fluoride ban as a “vital step” toward safeguarding children’s long-term wellness. He credited FDA Commissioner Dr. Marty Makary for his decisive leadership.
“This decision brings us one step closer to delivering on President Trump’s promise to Make America Healthy Again,”
— Robert F. Kennedy Jr.
Kennedy, a longstanding critic of fluoride use, has supported state-level efforts to curtail chemical exposure.
Adding fuel to the health reform momentum, Kennedy took aim at sugar consumption in a speech on April 23, calling it “poison” and urging policymakers to tackle its overuse in children’s diets. That same day, the International Dairy Foods Association (IDFA) pledged to eliminate artificial food dyes — including Red 3, Yellow 5, and Blue 1 — from dairy products offered in U.S. K–12 school meals by July 2026, aligning with nationwide efforts to clean up school nutrition.
What’s next?
While the FDA’s upcoming action does not affect topical fluoride products like toothpaste, mouthwash, or fluoride treatments at dental offices, the removal of oral supplements will leave a gap in fluoride access — especially for children outside fluoridated zones.
Critics argue that this decision may widen health disparities unless accompanied by clear alternative strategies and accessible public health interventions.
The FDA says its Center for Drug Evaluation and Research (CDER) will complete its review and provide further guidance by late October. In the meantime, pediatricians, dentists, and public health officials await clarification on how best to protect children’s oral health without compromising systemic well-being.
Stay ahead of the curve in oral health policy
Join the Dental News Pakistan Official WhatsApp Channel for expert updates, real-time alerts, and in-depth insights on major dental health decisions — like the FDA’s fluoride ban, its impact on pediatric care, and the latest reactions from top dental bodies.
JOIN NOW: Dental News Pakistan WhatsApp Channel